Proline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation

Cell Death and Differentiation

Volumn 21, Issue 1, 2014, Pages 113-123

  Lettieri Barbato, D ^a   Aquilano, K ^a   Baldelli, S ^b   Cannata, S M ^a   Bernardini, S ^a   Rotilio, G ^b   Ciriolo, M R ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SECTION OF MATHEMATICS   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

adipocytes; ageing; lipid signalling; mitochondrial metabolism; reactive oxygen species; starvation

Indexed keywords

CASPASE 9; CD31 ANTIGEN; CITRATE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROLINE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALORIC RESTRICTION; CARBONYLATION; CELL DEATH; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; INFLAMMATION; INTRAABDOMINAL FAT; MALE; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONTENT; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

MUS;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; APOPTOSIS; DIET; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION; LIPASE; MICE; MITOCHONDRIA; PPAR ALPHA; PROLINE OXIDASE; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84890123944     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.137     Document Type: Article

References (51)

1. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-Analysis. JAMA 2013; 309: 71-82.
2. Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9: 667-684.
3. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101.
4. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009; 29: 4467-4483.
5. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009; 68: 370-377.
6. Kramarow E, Lubitz J, Francis R Jr. Trends in the coronary heart disease risk profile of middle-Aged adults. Ann Epidemiol 2013; 23: 31-34.
7. Findeisen HM, Pearson KJ, Gizard F, Zhao Y, Qing H, Jones KL et al. Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS One 2011; 6: E18532.
8. Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL. Aging and regional differences in fat cell progenitors - A mini-review. Gerontology 2011; 57: 66-75.
9. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 2010; 107: 18226-18231.
10. Yilmaz M, Hotamisligil GS. Damned if you do, damned if you don't: The conundrum of adipose tissue vascularization. Cell Metab 2013; 17: 7-9.
11. Sung HK, Doh KO, Son JE, Park JG, Bae Y, Choi S et al. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab 2013; 17: 61-72.
12. Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem 2009; 107: 759-768.
13. Phang JM, Liu W, Zabirnyk O. Proline metabolism and microenvironmental stress. Annu Rev Nutr 2010; 30: 441-463.
14. Wek RC, Staschke KA. How do tumours adapt to nutrient stress? EMBO J 2010; 29: 1946-1947.
15. Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN et al. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J 2010; 29: 2082-2096.
16. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737.
17. Schoenborn V, Heid IM, Vollmert C, Lingenhel A, Adams TD, Hopkins PN et al. The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. Diabetes 2006; 55: 1270-1275.
18. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007; 92: 2292-2299.
19. Haemmerle G, Moustafa T, Woelkart G, Buttner S, Schmidt A, van de Weijer T et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-Alpha and PGC-1. Nat Med 2011; 17: 1076-1085.
20. Mottillo EP, Bloch AE, Leff T, Granneman JG. Lipolytic products activate peroxisome proliferator-Activated receptor (PPAR) alpha and delta in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem 2012; 287: 25038-25048.
21. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 2011; 14: 593-605.
22. Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 2010; 21: 589-598.
23. Cheng Z, White MF. Targeting Forkhead box O1 from the concept to metabolic diseases: Lessons from mouse models. Antioxid Redox Signal 2011; 14: 649-661.
24. Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem 2009; 284: 13296-13300.
25. Chakrabarti P, English T, Karki S, Qiang L, Tao R, Kim J et al. SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res 2011; 52: 1693-1701.
26. Gonzalez E, Flier E, Molle D, Accili D, McGraw TE. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci USA 2011; 108: 10162-10167.
27. Nakae J, Cao Y, Oki M, Orba Y, Sawa H, Kiyonari H et al. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 2008; 57: 563-576.
28. Gao CL, Zhu C, Zhao YP, Chen XH, Ji CB, Zhang CM et al. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol Cell Endocrinol 2010; 320: 25-33.
29. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009; 15: 1082-1087.
30. Guo W, Wong S, Xie W, Lei T, Luo Z. Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am J Physiol Endocrinol Metab 2007; 293: E576-E586.
31. Bashan N, Burdett E, Guma A, Sargeant R, Tumiati L, Liu Z et al. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 1993; 264: C430-C440.
32. Zhang L, Ebenezer PJ, Dasuri K, Fernandez-Kim SO, Francis J, Mariappan N et al. Aging is associated with hypoxia and oxidative stress in adipose tissue: Implications for adipose function. Am J Physiol Endocrinol Metab 2011; 301: E599-E607.
33. van der Vos KE, Coffer PJ. The extending network of FOXO transcriptional target genes. Antioxid Redox Signal 2011; 14: 579-592.
34. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26: 1749-1760.
35. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113-118.
36. Wu D, Ren Z, Pae M, Guo W, Cui X, Merrill AH et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007; 179: 4829-4839.
37. Haeusler RA, Accili D. The double life of Irs. Cell Metab 2008; 8: 7-9.
38. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal 2005; 7: 1021-1031.
39. Bender HU, Almashanu S, Steel G, Hu CA, Lin WW, Willis A et al. Functional consequences of PRODH missense mutations. Am J Hum Genet 2005; 76: 409-420.
40. Zarse K, Schmeisser S, Groth M, Priebe S, Beuster G, Kuhlow D et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab 2012; 15: 451-465.
41. Schroeder EA, Shadel GS. Alternative mitochondrial fuel extends life span. Cell Metab 2012; 15: 417-418.
42. Soliman GA, Acosta-Jaquez HA, Fingar DC. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 2010; 45: 1089-1100.
43. Gaidhu MP, Fediuc S, Anthony NM, So M, Mirpourian M, Perry RL et al. Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: Novel mechanisms integrating HSL and ATGL. J Lipid Res 2009; 50: 704-715.
44. Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 2010; 59: 775-781.
45. Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, Neumann-Haefelin E et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab 2012; 15: 713-724.
46. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8: 923-934.
47. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
48. Toyoda T, Kamei Y, Kato H, Sugita S, Takeya M, Suganami T et al. Effect of peroxisome proliferator-Activated receptor-Alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity (Silver Spring, MD) 2008; 16: 1199-1207.
49. Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y, Maki T et al. Peroxisome proliferatoractivated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: Comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005; 54: 3358-3370.
50. Aquilano K, Baldelli S, Pagliei B, Cannata SM, Rotilio G, Ciriolo MR. P53 orchestrates the PGC-1alpha-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid Redox Signal 2013; 18: 386-399.
51. Vigilanza P, Aquilano K, Baldelli S, Rotilio G, Ciriolo MR. Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. J Cell Physiol 2011; 226: 2016-2024.